Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
about
Homocysteine lowering interventions for peripheral arterial disease and bypass graftsFolic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular StudyHomocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementationIntimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.Homocysteine-lowering treatment: an overviewHomocysteine--a novel risk factor for vascular diseaseHyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathyEffect of folic acid and betaine supplementation on flow-mediated dilation: a randomized, controlled study in healthy volunteersIsoflavone supplementation and endothelial function in menopausal women.Microvascular changes in the diabetic foot.The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.Effects of chronic and acute consumption of fruit- and vegetable-puree-based drinks on vasodilation, risk factors for CVD and the response as a result of the eNOS G298T polymorphism.Folate supplementation reduces serum hsp70 levels in patients with type 2 diabetes.Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid.Homocysteine to hydrogen sulfide or hypertension.Flow-mediated dilatation.Vegan diet, subnormal vitamin B-12 status and cardiovascular healthNutritional supplementation and age-related macular degeneration.Effects of chronic consumption of fruit and vegetable puree-based drinks on vasodilation, plasma oxidative stability and antioxidant status.Folic acid mitigated cardiac dysfunction by normalizing the levels of tissue inhibitor of metalloproteinase and homocysteine-metabolizing enzymes postmyocardial infarction in miceVascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.Emergent cardiovascular risk factor: homocysteine.Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.The screening power of methylenetetrahydrofolate reductase C677T polymorphism versus plasma homocysteine concentration in patients with stenosis of the internal carotid arteryFolic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.Lipids and atherosclerosis.Thermolabile methylenetetrahydrofolate reductase C677T polymorphism and homocysteine are risk factors for coronary artery disease in Moroccan population.Novel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterinFolic acid supplementation improves vascular function in professional dancers with endothelial dysfunction.Folic Acid Represses Hypoxia-Induced Inflammation in THP-1 Cells through Inhibition of the PI3K/Akt/HIF-1α PathwayFolic acid: a marker of endothelial function in type 2 diabetes?Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte.Effect of losartan with folic acid on plasma homocysteine and vascular ultrastructural changes in spontaneously hypertensive ratsJanus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal.Measuring subclinical atherosclerosis: is homocysteine relevant?Possible relationship of folic Acid supplementation and improved flow-mediated dilation in premenopausal, eumenorrheic athletic women
P2860
Q24201135-5FDBDBE0-426B-4CDE-837C-35BDC20757D5Q24647967-1DB47C95-D01C-49B0-80B5-E61B89C515B0Q24791545-A62C94E2-EA82-4D62-9D66-762CF212E0DEQ24796491-ACEC1F8E-9FA0-4DCC-8474-64BF3B54BB6AQ28190121-337B1B0D-D4E1-412E-A47F-52D47EE6411FQ28353061-16CF3B4E-9958-4786-96BE-8B7D6C17E7A1Q28367720-F45A0020-DDE5-467F-8B35-C4FBB1BB8FA8Q28469018-83F0984E-D025-427D-8DD5-622596EAED59Q33183833-BBDA7E44-BCC6-45D1-AADD-4A6E3475358AQ33255016-436C1DCF-AA69-4EFF-B518-6B178D4F0710Q33370693-0B53AB69-7DA3-424F-8488-417C6B4E2991Q33418497-61D96098-6F72-4E4F-9440-AD4EDE1AF3DFQ33716793-058EDCA2-34DE-4A7E-8126-6D73B8290688Q33863914-1A14AD2C-29E7-4568-BC08-08E5F475299AQ34066620-FDCBCC85-87BF-495B-A9E8-EF3AB75C3846Q34078578-CD50BA84-AF6D-4FCA-A557-6D91C4AC2838Q34091797-97BF5A42-8CF1-49AF-952E-5F1B9BD220ECQ34187039-78E9FC5E-F3B2-49F9-9BA2-809FD7079B49Q34351569-BFFA197C-2BB6-495F-99B8-70BC44A92F3EQ34357653-7FC83F89-74C6-4E37-B5AC-DE826EA24133Q34395823-0F3EF575-8B4D-40AD-9EA7-06060EF6ABF3Q34548859-13CC15F2-26DD-4EC4-ADD4-12832D4C9D75Q34758240-721D306F-2D05-4AA7-893F-E7F907DF6DF8Q35055199-0814BF27-D8AC-4D22-A95E-491043EC243AQ35062317-2B734629-E6DA-4E0F-9ED9-8048C557D0C3Q35080666-DDD232AC-45AE-4B8D-9E9E-692B83990FDDQ35600410-3075084F-7F29-423F-9D06-3CCD1752B543Q35600437-66C87F6C-501E-44FF-BD94-258F9B38EAA3Q35600441-0EC84159-0301-43E9-AFA4-CA9C553824F1Q35723517-EF77B20C-1EFB-4246-A8E8-46EDB0651CEDQ35753030-99065CD8-6DE4-42BA-A2C7-ADBE99B50350Q35848552-7EFEE08D-D915-4931-A6E5-245031726FDFQ35895448-92835A63-BCA5-4896-B2B5-E0829C64AA87Q35955970-F8EFAE13-B3CF-4392-9455-0A0DD00E1EA5Q36012812-0504A4B2-EC8E-4752-B46C-13B803BF2504Q36279580-276FF931-0141-43BE-9547-DA33F53B37F7Q36375258-BAF64019-3BE1-4305-9774-72B34D525812Q36666934-6A18CE84-80B2-4886-82BC-9AE794256BAFQ36996494-B40FCEF2-0418-4444-971F-31C4F7B6FCCCQ37080994-AC38D77A-98B0-4DB5-970A-9D1F65B9C36E
P2860
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
@en
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
@nl
type
label
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
@en
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
@nl
prefLabel
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
@en
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
@nl
P2093
P1476
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.
@en
P2093
P304
P356
10.1016/S0735-1097(99)00469-6
P407
P577
1999-12-01T00:00:00Z